EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Leadership Insights: 6thAnnual Rare & Genetic Kidney Disease Drug Development Summit
The most important shift I have seen is the move from phenotypefirst to genotypefirst thinking and that is changing everything from diagnosis to trial...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
From Pipelines to Platforms: How AI Investments Are Transforming Biotech and Pharma’s Operating Model
Artificial intelligence has rapidly emerged as one of the defining themes in the pharmaceutical industry Over the last few years major drugmakers have announced a steady stream of investments partnerships and internal initiatives aimed at bringing AI into research and development manufacturing quality and commercial operations Much of the attention has focused on faster drug discovery
-
Techno Trends
University of Cincinnati and Johns Hopkins Develop Nanofibre-Based Therapy for Glioblastoma
Researchers from the University of Cincinnati and Johns Hopkins Medicine have developed a promising nanofibrebased drug delivery system designed to improve treatment outcomes for glioblastoma
-
Projects
Vetter Invests €500 Million to Expand New Saarlouis Injectable Drug Manufacturing Facility
Vetter has started construction of its new pharmaceutical manufacturing facility in Saarlouis Germany supported by an investment of nearly million The project will expand the companys commercial manufacturing capabilities for injectable medicines and support increasing global demand for complex drug products
-
Research Insights
A simple model captures key characteristics of biological non-deterministic genotype-phenotype maps
By connecting genotypic mutations to the higherlevel phenotypes relevant for selection genotypephenotype GP maps play a key role in evolution GP maps are typically investigated using computational models
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Regulatory Affairs Outsourcing: Benefits, Challenges, and Best Practices
Kate Williamson
A major transformation of regulatory compliance to pharma, biotech, and medical device firms is the outsourcing of regulatory activities to meet their needs through the availability of specialized kno...
-
2
Drug Resistance in Bacteria: An Emerging Crisis
Ayush Amod
Sintu Kumar Samanta
Bacterial infections adversely impact global public health. Most bacterial infections in humans are associated with biofilm formation which makes them highly resistant to commercially available antibi...
-
3
Artificial Intelligence in Clinical Trials
Reva Rajendra Joshi
Ashwin Kuchekar
Artificial intelligence is a computer program that extracts concepts and relationships from data and learns on its own from data patterns. A clinical trial is a time-consuming, costly process with a v...
-
4
Patient-Centric Clinical Trials: Shaping the Future of Medical Research
Kate Williamson
This article explores the transformative shift toward patient-centric clinical trials, emphasizing active patient involvement in study design, recruitment strategies, and the integration of Patient-Re...
-
5
Embracing AI to Revolutionize Drug Safety: A Call for Modernizing Pharmacovigilance Practices
Pramod Kumar
Pharmacovigilance is vital for protecting patients, but traditional approaches fail to address diverse populations and real-world complexities. This article highlights how AI, particularly LLMs and Ge...
press releasesRead more...
Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations
Takeda TSENYSETAK announced positive topline results for the Phase randomized multicenter doubleblind study comparing zasocitinib TAK an investigational nextgeneration
U.S. FDA Accepts Takeda's Application for Intravenous ENTYVIO® (vedolizumab) in Pediatric Ulcerative Colitis and Crohn's Disease
Takeda today announced the US Food and Drug Administration FDA has accepted for review its supplemental Biologics License Application sBLA for intravenous IV ENTYVIO vedolizumab for the treatment
XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target
XtalPi HK a leading platform in artificial intelligence AI and roboticsdriven drug discovery today announced a strategic partnership with a prominent international biopharmaceutical company
Trust in medicines shaken by counterfeit crisis, survey finds
A new survey reveals widespread concern among respondents about counterfeit medication with six in worried their prescribed drugs might be fake or substandard Commissioned by Avery Dennison
Events Read more...
15 - 18
Jun 2026MedTech Summit 2026
JW Marriott Hotel Berlin, Berl...
16 - 17
Jun 2026LogiPharma Asia 2026
Equarius Hotel, Singapore
16 - 18
Jun 2026CPHI & PMEC China 2026
Shanghai New International Exp...
16 - 17
Jun 2026PDA Sterile Manufacturing & Regulatory Excellence
Novotel Bangkok on Siam Square...
18 - 20
Jun 2026CCT 2026
Barcelona, Spain
23 - 24
Jun 2026Supply Chain USA 2026
Chicago, IL
24 - 25
Jun 20266th Edition Drug Safety Symposium 2026
Courtyard by Marriott, Mumbai,...
25 - 26
Jun 2026Pharmacology and Toxicology 2026
Paris, France
LATEST NEWSRead more...
Harbour BioMed’s IND Application for HBM7004 Accepted in China for Advanced Solid Tumours
Harbour BioMed has announced that Chinas National Medical Products Administration NMPA has accepted the Investigational New Drug IND application for HBM for the treatment of advanced solid tumours
Orionis Biosciences Expands Partnership with Novartis to Develop Molecular Glue Therapies
Orionis Biosciences has entered into a multiyear collaboration with Novartis to discover and develop molecular glue medicines targeting difficulttoaddress diseases across multiple therapeutic areas
Zai Lab Secures China Approval for TIVDAK in Recurrent or Metastatic Cervical Cancer
Zai Lab has received approval from Chinas National Medical Products Administration NMPA for TIVDAK tisotumab vedotin for injection to treat adult patients with recurrent or metastatic cervical cancer whose disease has progressed during or after chemotherapy
Johnson & Johnson to Acquire Firefly Bio to Strengthen Oncology Pipeline
Johnson Johnson has signed a definitive agreement to acquire biotechnology company Firefly Bio Inc for billion in cash
Alvotech Announces FDA Acceptance of BLA for Proposed Entyvio Biosimilar AVT16
Alvotech has announced that the US Food and Drug Administration FDA has accepted for review a Biologics License Application BLA for AVT a proposed interchangeable biosimilar to Entyvio vedolizumab for intravenous administration
Japan Grants Orphan Drug Designation to Quoin’s QRX003 for Netherton Syndrome
Quoin Pharmaceuticals has received Orphan Drug Designation from Japans Ministry of Health Labour and Welfare MHLW for QRX its investigational treatment for Netherton Syndrome
